The Indian pharmaceutical sector has a long history of developing and delivering world-class products at affordable costs across the globe. As per IBEF data updated in June 2022, India has the greatest number of US FDA-approved units (741 as of August 2021). Indian pharma companies offer produ...
The Indian Pharmaceutical market (IPM) has registered strong growth of 9.5 per cent toRs.10,056 crore during January 2018 which highest monthly growth as compared to last four months. According to AIOCD Pharmasofttech AWACS report the IPM growth during the first ten months of 2017-18 restricted...
The Indian Pharmaceutical Market (IPM) has registered a growth of 1.1% for the month of February 2021, after registering a growth of 4.5% for the month of January 2021. According to AIOCD AWACS report, the IPM has recorded sales of Rs. 1,46,104 crore for moving annual total (MAT) basi...
Pharmacy Market Size, Share & Trends Analysis Report By Product (Prescription, OTC), By Type (Retail Pharmacy, ePharmacy), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030 Report ID: GVR-4-68039-701-1 Number of Report Pages: 145 Format: PDF, Horizon Databook ...
The Indian pharmaceuticals industry is expected to log in a revenue growth of 8-10 percent in current fiscal aided by a steady domestic growth and increased exports to regulated markets, even as semi-regulated markets face headwinds, according to a report by Crisil. The report covers 186 drug ...
Thousands of global companies will gather to get new insights and contacts in what is predicted to be pharma’s most competitive marketplace in 2023. Comments Comment Log In To Comment New User? Create Account Other Topics India Pharma manufacturing Covid19 Indian Biotech Cell & Gene the...
KRÜSS is one of the leading providers of optical and force tensiometers to the companies involved in adhesion & coating, spraying & printing, cleaning, food & beverages, medical & pharma surface treatment, and wetting & coating of textiles. To strengthen its market position and to broaden ...
As both of these areas become more important, Indian producers are likely to take a large role on the world stage – and potentially partner with global pharma companies to market their wares outside of India. Indian companies have also started entering into the realm of R&D; some of the ...
The global ophthalmic disease therapeutics market size was USD 35.57 billion in 2023. The market is projected to grow from USD 37.74 billion in 2024 to USD 62.57 billion by 2032, exhibiting a CAGR of 6.5% during the forecast period. North America dominated the global market with a share of ...
Food Enzymes Market Size is Anticapted to Reach USD 4.8 Billion by 2032, Growing at a CAGR of 5.68% Due to Increasing the Demand for Enzymes in the Food Industry